{{chembox
| verifiedrevid = 389104871
| Name = Dichlorotetrakis(dimethyl sulfoxide) ruthenium (II)
| ImageFileL1 = RuCl2-dmso4.PNG
| ImageSizeL1 = 150 px
| ImageFileR1 = Cis-fac-dichlorotetrakis(dimethyl-sulfoxide)ruthenium(II)-from-xtal-2008-3D-balls.png
| ImageSizeR1 = 150 px
| ImageFile2 = RuCl2(dmso)4 (Strem).jpg
| ImageSize2 = 300 px
| SystematicName = Ruthenium, dichlorotetrakis(sulfinylbis(methane))- (9CI)
| OtherNames = 二氯四(二甲亚砜)合钌<BR>四(二甲基亚砜)二氯化钌<BR>氯化四(二甲基亚砜)合钌(II)
| Section1 = {{Chembox Identifiers
| CASNo = 11070-19-2
| CASNo_Ref = 
}}
| Section2 = {{Chembox Properties
| Formula = C<sub>8</sub>H<sub>24</sub>Cl<sub>2</sub>O<sub>4</sub>RuS<sub>4</sub>
| MolarMass = 484.51 g·mol<sup>−1</sup>
| Appearance = 黄色晶体
| Solubility = 易溶于水
| SolubleOther = [[硝基甲烷|硝基甲烷]]、[[二氯甲烷|二氯甲烷]]、[[氯仿|氯仿]]1
}}
| Section3 = {{Chembox Structure
| Coordination = 八面体配位
}}
}}

'''二氯化四(二甲基亚砜)合钌(II)'''是一种[[配位化合物|配位化合物]]，化学式为RuCl<sub>2</sub>(DMSO)<sub>4</sub>，其中，DMSO为[[二甲基亚砜|二甲基亚砜]]的英文缩写。它存在顺式和反式两种构型，这两种构型都是已知的，但顺式构型（如右图）更为常见。顺式异构体为黄色固体，在空气中稳定，可溶于一部分有机溶剂。它是潜在的抗癌药物。

==结构与制备==
顺式异构体为DMSO配体连接异构。<ref>{{cite journal | author = Enzo Alessio | title = Synthesis and reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide compounds | journal = [[Chem._Rev.|Chem. Rev.]] | year = 2004 | volume = 104 | pages = 4203–4242 | doi = 10.1021/cr0307291 | issue = 9}}</ref>三个DMSO配体为S-键合，另一个为O-键合，对于两个Cl来说是顺式构型。反式异构体也是黄色的，但四个DMSO配体都是S-键合的。顺式可以通过热反应得到，而反式由顺式通过[[紫外线|紫外线]]照射得到。<ref name=Bratsos2/>

<center>
{|align="center"  class="wikitable"
|<center>[[File:Cis-fac-dichlorotetrakis(dimethyl-sulfoxide)ruthenium(II)-from-xtal-2008-3D-balls.png|200px]]</center>||<center>[[File:Trans-dichloridotetrakis(dimethyl-sulfoxide)ruthenium(II)-from-xtal-1990-3D-balls.png|200px]]</center>
|-
|<center>''cis'',''fac''-异构体</center>||<center>''trans'',''mer''-异构体</center>
|}
</center>

这些配合物最初由[[三氯化钌|三氯化钌]]的DMSO溶液在[[氢气|氢气]]气氛中加热得到。<ref name=James>{{cite journal |author1=B. R. James |author2=E. Ochiai|author3=G.I. Rempel | journal = Inorganic and Nuclear Chemistry Letters| volume = 7 | pages = 781–784 | year = 1971 | doi = 10.1016/0020-1650(71)80091-0 | title = Ruthenium (II) halide dimethylsulphoxide complexes from hydrogenation reactions | issue = 8}}</ref>另一种不使用氢气的方法也得到了文献报道。<ref name=Bratsos2>{{cite journal |author1=I. Bratsos |author2=E. Alessio | journal = [[Inorganic_Syntheses|Inorganic Syntheses]] | volume = 35 | pages = 148–152 | year = 2010 | title = Ruthenium(II) Chloro Complexes of dimethylsulfoxide | doi = 10.1002/9780470651568.ch8 }}</ref><ref>{{cite journal |author1=Nagy, E. M. |author2=Pettenuzzo, A. | journal = [[Chemistry:_A_European_Journal|Chemistry: A European Journal]] | volume = 18 | pages = 14464–14472 | year = 2012 | title = Ruthenium(II/III)-Based Compounds with Encouraging Antiproliferative Activity against Non-small-Cell Lung Cancer | doi=10.1002/chem.201202171}}</ref>

==潜在应用==
RuCl<sub>2</sub>(DMSO)<sub>4</sub>最初于20世纪80年代早期被认定为抗癌药。<ref>{{cite journal|last1=Sava|first1=Gianni|last2=Giraldi|first2=Tullio|last3=Mestroni|first3=Giovanni|last4=Zassinovich|first4=Grazia|title=Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma|journal=Chemico-Biological Interactions|date=July 1983|volume=45|issue=1|pages=1–6|doi=10.1016/0009-2797(83)90037-6}}</ref>后期进一步的研究<ref>{{cite journal|last1=Coluccia|first1=Mauro|last2=Sava|first2=Gianni|last3=Loseto|first3=Francesco|last4=Nassi|first4=Anna|last5=Boccarelli|first5=Angela|last6=Giordano|first6=Domenico|last7=Alessio|first7=Enzo|last8=Mestroni|first8=Giovanni|title=Anti-leukaemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on subline|journal=European Journal of Cancer|date=January 1993|volume=29|issue=13|pages=1873–1879|doi=10.1016/0959-8049(93)90541-M}}</ref><ref name=Bratsos>{{cite journal |author1=Bratsos, I |author2=Serli, B |author3=Zangranko, E |author4=Katsaros, N |author5=Alessio, E. | title = Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: A new strategy that might lead to improved activity | journal =[[Inorg._Chem.|Inorg. Chem.]] | volume = 46 | pages = 975–992 | doi = 10.1021/ic0613964 | year = 2007 | pmid=17257042 | issue = 3}}</ref>使得其它含DMSO的钌化合物得到了开发，其中一些进行了早期的临床试验。<ref>{{cite journal|last1=Enzo Alessio|first1=Bentham Science Publisher|last2=Giovanni Mestroni|first2=Bentham Science Publisher|last3=Alberta Bergamo|first3=Bentham Science Publisher|last4=Gianni Sava|first4=Bentham Science Publisher|title=Ruthenium Antimetastatic Agents|journal=Current Topics in Medicinal Chemistry|date=1 November 2004|volume=4|issue=15|pages=1525–1535|doi=10.2174/1568026043387421}}</ref>

==参考文献==
{{Reflist}}

{{钌化合物}}

[[Category:钌配合物|Category:钌配合物]]
[[Category:二甲基亚砜配合物|Category:二甲基亚砜配合物]]
[[Category:1970年代发现的物质|Category:1970年代发现的物质]]
[[Category:氯配合物|Category:氯配合物]]